01 Aug 2023
Replimune to Present at Two Upcoming Inv ...
WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. NASDAQ: REPL, a clinical stage biotechnology company p ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.